PEREGRINE CAPITAL MANAGEMENT LLC – Adaptive Biotechnologies Corporation Transaction History
PEREGRINE CAPITAL MANAGEMENT LLC portfolio value:
$1.98M
portfolio value
PEREGRINE CAPITAL MANAGEMENT LLC quarter portfolio value change:
-11.99%
quarter
Adaptive Biotechnologies Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -5.18% | -15.22K shares | -393K | $7.12 | 278.73K |
Q2 2022 | share | Decrease | -7.60% | -24.19K shares | -2.03M | $8.09 | 293.95K |
Q1 2022 | share | Decrease | -6.28% | -21.31K shares | -5.10M | $13.88 | 318.14K |
Q4 2021 | share | Increase | +22.40% | 62.11K shares | 98K | $28.33 | 339.46K |
Q3 2021 | share | Decrease | -13.85% | -44.57K shares | -3.72M | $33.99 | 277.34K |
Q2 2021 | share | Increase | +13.24% | 37.62K shares | 1.70M | $40.86 | 321.92K |
Q1 2021 | share | Decrease | -4.22% | -12.51K shares | -6.10M | $40.26 | 284.29K |
Q4 2020 | share | Decrease | -9.30% | -30.42K shares | 1.63M | $59.13 | 296.80K |
Q3 2020 | share | Decrease | -12.28% | -45.81K shares | -2.13M | $48.63 | 327.23K |
Q2 2020 | share | Decrease | -3.25% | -12.54K shares | 7.33M | $48.38 | 373.04K |
Q1 2020 | share | Increase | +30.47% | 90.04K shares | 1.86M | $27.78 | 385.59K |
Q4 2019 | share | Increase | 0.00% | 295.54K shares | 8.84M | $29.92 | 295.54K |